1315 Capital
Overview
1315 Capital is a private investment firm with over $1 billion of assets under management that provides expansion and growth capital to commercial-stage healthcare services, pharmaceutical & medical technology outsourcing, medical technology, and health & wellness companies . The firm targets both minority and majority investments in companies where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Primrose Bio | Sep 2026 | Growth Equity | Co-investor |
| miraDry, Inc. | May 2021 | M&A | Co-investor |
| Experic | Oct 2024 | Growth Equity | Lead |
| Innovative Health Solutions, L.L.C. | - | VC Round | Co-investor |
| Homestead Smart Health Plans | Sep 2021 | Buyout/LBO | Lead |
For institutional investors. Book with your work email.
Key People
Antony Koblish
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 1315 Capital based?
1315 Capital is headquartered in Philadelphia, Pennsylvania, United States.
When was 1315 Capital founded?
1315 Capital was founded in 2014.
How many portfolio companies does 1315 Capital have?
1315 Capital has 19 portfolio companies in Caplight's dataset.
What are some companies in 1315 Capital's portfolio?
Portfolio companies visible on Caplight include Primrose Bio, miraDry, Inc., Experic, Innovative Health Solutions, L.L.C., Homestead Smart Health Plans.
What was 1315 Capital's most recent investment shown here?
1315 Capital's most recent investment in this portfolio sample was in Primrose Bio in 2026.
What sectors does 1315 Capital focus on?
1315 Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does 1315 Capital focus on?
1315 Capital typically invests at the Mid stage.
What is 1315 Capital's AUM?
1315 Capital's assets under management are estimated between $1.0B and $10.0B.